AlemtuzumabHypertension and erythematous and pruritic skin rashes: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1836卷 / 1期

关键词：

D O I：

10.1007/s40278-021-87855-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：36 / 36

相关论文

共 50 条

[21] DoxycyclinePhototoxic rashes: 3 case reports
[J]. Reactions Weekly, 2016, 1601 (1) : 111 - 111
[22] Aspirin/paracetamolEye swelling, rashes and itching: 2 case reports
[J]. Reactions Weekly, 2014, 1520 (1) : 31 - 31
[23] DocetaxelPersistent supravenous erythematous eruption: 2 case reports
[J]. Reactions Weekly, 2015, 1582 (1) : 183 - 183
[24] AripiprazoleMacular skin rashes: case report
[J]. Reactions Weekly, 2015, 1539 (1) : 48 - 48
[25] AfatinibMucocutaneous skin rashes: case report
[J]. Reactions Weekly, 2018, 1684 (1) : 17 - 17
[26] MogamulizumabSystemic skin rashes: case report
[J]. Reactions Weekly, 2017, 1639 (1) : 195 - 195
[27] Antiepileptic drugsSkin rashes: 18 case reports
[J]. Reactions Weekly, 2010, 1329 (1) : 9 - 9
[28] Itraconazole/potassium-iodideSkin rashes and hypothyroidism: 2 case reports
[J]. Reactions Weekly, 2023, 1941 (1) : 232 - 232
[29] TocilizumabInjection site reaction presenting as pruritic erythematous rash: case report
[J]. Reactions Weekly, 2019, 1757 (1) : 301 - 301
[30] Erlotinib/gefitinibSkin rashes: 4 case reports
[J]. Reactions Weekly, 2014, 1532 (1) : 92 - 92

← 1 2 3 4 5 →